Inventor

John R. Jacobsen

Inventor

San Mateo, CA, US

Overview

2002–2020

Patent span

Chemistry

Primary field (CPC C)

Patents· 61 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%

C07DHeterocyclic compounds28%

A61KPreparations for medical, dental or toiletry purposes17%

C07CAcyclic or carbocyclic compounds12%

C09JAdhesives3%

C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds3%

C08LCompositions of macromolecular compounds2%

C07BGeneral methods of organic chemistry2%

Y10TTechnical subjects covered by former us classification2%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%

PatentTitleYear

10,836,744Diamide compounds having muscarinic receptor antagonist and b2 adrenergic receptor agonist activity2020 10,745,3948-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists2020 10,590,107Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity2020 10,526,330JAK kinase inhibitor compounds for treatment of respiratory disease2020 10,414,954Water-based pressure-sensitive adhesive compositions2019 10,377,7518-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists2019 10,358,433Diamide compounds having muscarinic receptor antagonist and b2 adrenergic receptor agonist activity2019 10,208,232Adhesive composition2019 10,138,220Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity2018 10,100,049JAK kinase inhibitor compounds for treatment of respiratory disease2018 10,081,6268-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists2018 10,081,745Water-based pressure-sensitive adhesive compositions2018 9,975,875Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity2018 9,890,301'Water-based pressure-sensitive adhesive compositions'2018 9,803,114'Acrylic adhesive composition with controlled molecular weight'2017 9,771,350'Diamide compounds having muscarinic receptor antagonist and Î²2 adrenergic receptor agonist activity'2017 9,695,343'Hot melt processable pressure sensitive adhesives containing fibrous materials'2017 9,682,957'Diamide compounds having muscarinic receptor antagonist and Î²2 adrenergic receptor agonist activity'2017 9,663,509'8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2017 9,572,802'Diamide compounds having muscarinic receptor antagonist and Î²2 adrenergic receptor agonist activity'2017 9,394,275'Diamide compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity'2016 9,206,172'8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2015 9,000,173'Diamide compounds having muscarinic receptor antagonist and Î²2 adrenergic receptor agonist activity'2015 8,927,573'8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2015 8,816,088'Diamide compounds having muscarinic receptor antagonist and Î²2 adrenergic receptor agonist activity'2014 8,703,791'3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists'2014 8,664,242'8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2014 8,551,978'Diamide compounds having muscarinic receptor antagonist and Î²2 adrenergic receptor agonist activity'2013 8,518,966'Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2013 8,497,287'Aminotetralin compounds as mu opioid receptor antagonists'2013 8,318,765'3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists'2012 8,314,128'Aminotetralin compounds as mu opioid receptor antagonists'2012 8,268,863'Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2012 8,263,618'8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists'2012 8,138,345'Diamide compounds having muscarinic receptor antagonist and Î²2 adrenergic receptor agonist activity'2012 8,106,232'3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists'2012 8,101,791'Aminotetralin compounds as mu opioid receptor antagonists'2012 7,994,165'Aryl aniline derivatives as Î²2 adrenergic receptor agonists'2011 7,964,730'Amino-substituted ethylamino Î²2 adrenergic receptor agonists'2011 7,947,710'Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2011 7,902,221'Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2011 7,622,467'Aryl aniline derivatives as Î²2 adrenergic receptor agonists'2009 7,622,508'8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists'2009 7,582,765'Aryl aniline Î²2 adrenergic receptor agonists'2009 7,566,785'Amidine substituted aryl aniline compounds'2009 7,553,971'Aryl aniline Î²2 adrenergic receptor agonists'2009 7,452,995'Aryl aniline Î²2 adrenergic receptor agonists'2008 7,399,863'Amino-substituted ethylamino Î²2 adrenergic receptor agonists'2008 7,220,758'Ether substituted imidazopyridines'2007 7,125,890'Ether substituted imidazopyridines'2006 7,125,892'Aryl aniline Î²2 adrenergic receptor agonists'2006 6,949,568'Aryl aniline Î²2 adrenergic receptor agonists'2005 6,797,718'Ether substituted imidazopyridines'2004 6,670,376'Aryl aniline 2 adrenergic receptor agonists'2003 6,653,323'Aryl aniline 2 adrenergic receptor agonists'2003 6,576,791'Local anesthetic compounds and uses'2003 6,495,681'Local anesthetic compounds and uses'2002 6,462,034'Local anesthetic compounds and uses'2002 6,436,919'Local anesthetic compounds'2002 6,355,637'Local anesthetic compounds'2002 6,337,423'Local anesthetic compounds and uses'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2014Patents assigned to THERAVANCE INC (32)· patent assignee history

2002–2003Based in San Francisco, CA, US· patent location history

2003–2020Based in San Mateo, CA, US· patent location history

2004–2019Patents assigned to 3M INNOVATIVE PROPERTIES CO (9)· patent assignee history

2004–2019Based in Woodbury, MN, US· patent location history

2012–2017Patents assigned to JACOBSEN JOHN R (17)· patent assignee history

2012–2017Patents assigned to LONG DANIEL D (13)· patent assignee history

2014–2020Patents assigned to THERAVANCE RESPIRATORY CO LLC (11)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
THERAVANCE INC	32	2002–2014
JACOBSEN JOHN Rself	17	2012–2017
LONG DANIEL D	13	2012–2017
THERAVANCE RESPIRATORY CO LLC	11	2014–2020
3M INNOVATIVE PROPERTIES CO	9	2004–2019

Locations

Location	Patents	Span
San Mateo, California, US	46	2003–2020
Woodbury, Minnesota, US	9	2004–2019
San Francisco, California, US	6	2002–2003